Population Pharmacokinetic Modeling: The Importance of Informative Graphics

AbstractPurpose. The usefulness of several modelling methods were examined in the development of a population pharmacokinetics model for cefepime. Methods. The analysis was done in six steps: (1) exploratory data analysis to examine distributions and correlations among covariates, (2) determination of a basic pharmacokinetic model using the NON-MEM program and obtaining Bayesian individual parameter estimates, (3) examination of the distribution of parameter estimates, (4) multiple linear regression (MLR) with case deletion diagnostics, generalized additive modelling (GAM), and tree-based modelling (TBM) for the selection of covariates and revealing structure in the data, (5) final NONMEM modelling to determine the population PK model, and (6) the evaluation of final parameter estimates. Results. An examination of the distribution of individual clearance (CL) estimates suggested bimodality. Thus, the mixture model feature in NONMEM was used for the separation of subpopulations. MLR and GAM selected creatinine clearance (CRCL) and age, while TBM selected both of these covariates and weight as predictors of CL. The final NONMEM model for CL included only a linear relationship with CRCL. However, two subpopulations were identified that differed in slope and intercept. Conclusions. The findings suggest that using informative graphical and statistical techniques enhance the understanding of the data structure and lead to an efficient analysis of the data.

[1]  N. Draper,et al.  Applied Regression Analysis , 1966 .

[2]  Lewis B. Sheiner,et al.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  D. Stanski,et al.  A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolam , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  Lewis B. Sheiner,et al.  Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  R. Cook.  Detection of influential observation in linear regression , 2000 .

[6]  Rupert G. Miller.  The jackknife-a review , 1974 .

[7]  R. Tibshirani,et al.  Generalized Additive Models , 1991 .

[8]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[9]  S. Weisberg,et al.  Criticism and Influence Analysis in Regression , 1982 .

[10]  G. Matzke,et al.  Pharmacokinetics of cefepime in subjects with renal insufficiency , 1990, Clinical pharmacology and therapeutics.

[11]  Marie Davidian,et al.  Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[12]  D. V. Hinkley,et al.  Jackknife confidence limits using Student t approximations , 1977 .

[13]  K. Pittman,et al.  Effects of age and gender on pharmacokinetics of cefepime , 1992, Antimicrobial Agents and Chemotherapy.

[14]  J. Magny,et al.  Population pharmacokinetics of midazolam in neonates , 1994, Clinical pharmacology and therapeutics.

[15]  John W. Tukey,et al.  Exploratory Data Analysis. , 1979 .

[16]  K. Pittman,et al.  High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine , 1987, Antimicrobial Agents and Chemotherapy.

[17]  M. H. Quenouille.  NOTES ON BIAS IN ESTIMATION , 1956 .

[18]  S. Shapiro,et al.  An Approximate Analysis of Variance Test for Normality , 1972 .